Depression and social phobia secondary to alcohol dependence

Neuropsychobiology

Volumn 56, Issue 2-3, 2008, Pages 111-118

  Olgiati, Paolo ^a   Liappas, Ioannis ^b   Malitas, Petros ^d   Piperi, Christina ^c   Politis, Antonis ^b   Tzavellas, Elias O ^b   Zisaki, Aikaterini ^c   Ferrari, Barbara ^a   De Ronchi, Diana ^a   Kalofoutis, Anastasios ^c,d   Serretti, Alessandro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d European Centre for the Quality of Life ECQuaL   (Greece)

Author keywords

Alcohol; Anxiety; Comorbidity; Depression; Detoxification; Social phobia

Indexed keywords

ADULT; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; DEPRESSION; FEMALE; GENERALIZED ANXIETY DISORDER; HAMILTON SCALE; HOSPITALIZATION; HUMAN; HYPOCHONDRIASIS; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; SOCIAL PHOBIA;

ADULT; AGED; ALCOHOLISM; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PHOBIC DISORDERS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REGRESSION ANALYSIS;

EID: 40349102393     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112952     Document Type: Article

References (80)

1. Cornelius JR, Bukstein O, Salloum I, Clark D: Alcohol and psychiatric comorbidity. Recent Dev Alcohol 2003;16:361-374.
2. Schuckit MA: Alcohol and depression: a clinical perspective. Acta Psychiatr Scand Suppl 1994;377:28-32.
3. Brown SA, Inaba RK, Gillin JC, Schuckit MA, Stewart MA, Irwin MR: Alcoholism and affective disorder: clinical course of depressive symptoms. Am J Psychiatry 1995;152:45-52.
4. Leibenluft E, Madden PA, Dick SE, Rosenthal NE: Primary depressives with secondary alcoholism compared with alcoholics and depressives. Compr Psychiatry 1993;34:83-86.
5. Schuckit MA, Tipp JE, Bergman M, Reich W, Hesselbrock VM, Smith TL: Comparison of induced and independent major depressive disorders in 2945 alcoholics. Am J Psychiatry 1997;154:948-957.
6. Bijl RV, Ravelli A, van Zessen G: Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 1998;33:587-595.
7. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC: Lifetime cooccurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997;54:313-321.
8. Schneider U, Altmann A, Baumann M, Bernzen J, Bertz B, Bimber U, Broese T, Broocks A, Burtscheidt W, Cimander KF, Degkwitz P, Driessen M, Ehrenreich H, Fischbach E, Folkerts H, Frank H, Gurth D, Havemann-Reinecke U, Heber W, Heuer J, Hingsammer A, Jacobs S, Krampe H, Lange W, Lay T, Leimbach M, Lemke MR, Leweke M, Mangholz A, et al: Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: the first multicentre study in Germany. Alcohol Alcohol 2001;36:219-223.
9. Terra MB, Barros HM, Stein AT, Figueira I, Jorge MR, Palermo LH, Athayde LD, Goncalves MS, Spanemberg L, Possa MA, Daruy Filho L, Da Silveira DX: Social anxiety disorder in 300 patients hospitalized for alcoholism in Brazil: high prevalence and undertreatment. Compr Psychiatry 2006;47:463-467.
10. Liappas J, Paparrigopoulos T, Tzavellas E, Rabavilas A: Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:55-60.
11. Liappas J, Paparrigopoulos T, Malitas P, Tzavellas E, Christodoulou G: Mirtazapine improves alcohol detoxification. J Psychopharmacol 2004;18:88-93.
12. Liappas J, Paparrigopoulos T, Tzavellas E, Christodoulou G: Impact of alcohol detoxification on anxiety and depressive symptoms. Drug Alcohol Depend 2002;68:215-220.
13. Wetterling T, Junghanns K: Psychopathology of alcoholics during withdrawal and early abstinence. Eur Psychiatry 2000;15:483-488.
14. Brown SA, Irwin M, Schuckit MA: Changes in anxiety among abstinent male alcoholics. J Stud Alcohol 1991;52:55-61.
15. Terra M, Figueira I, Barros H: Impact of alcohol intoxication and withdrawal syndrome on social phobia and panic disorder in alcoholic inpatients. Rev Hosp Clin Fac Med Sao Paulo 2004;59:187-192.
16. Liappas J, Paparrigopoulos T, Tzavellas E, Christodoulou G: Alcohol detoxification and social anxiety symptoms: a preliminary study of the impact of mirtazapine administration. J Affect Disord 2003;76:279-284.
17. Serretti A, Mandelli L, Liappas J, Albani D, Forloni G, Malitas PN, Kalofoutis A: Interleukin-1 alpha and beta, TNF and HTTLPR gene variants are not associated with alcoholism toxicity and with detoxification outcome. Neurosci Lett 2006;406:107-112.
18. Lepine J, Pelissolo A: Comorbidity and social phobia: clinical and epidemiological issues. Int Clin Psychopharmacol 1996;11(suppl 3):35-41.
19. Schneier F, Johnson J, Hornig C, Liebowitz MR, Weissman M: Social phobia: comorbidity and morbidity in an epidemiological sample. Arch Gen Psychiatry 1992;49:282-288.
20. Moscovitch D, Hofmann S, Suvak M, In-Albon T: Mediation of changes in anxiety and depression during treatment of social phobia. J Consult Clin Psychol 2005;73:945-952.
21. Kumari M, Ticku MK: Regulation of NMDA receptors by ethanol. Prog Drug Res 2000;54:152-189.
22. Crews F, Buckley T, Dodd P, Ende G, Foley N, Harper C, He J, Innes D, Loh el-W, Pfefferbaum A, Zou J, Sullivan E: Alcoholic neurobiology: changes in dependence and recovery. Alcohol Clin Exp Res 2005;29:1504-1513.
23. Khantzian E: Self-regulation and self-medication factors in alcoholism and the addictions: similarities and differences. Recent Dev Alcohol 1990;8:255-271.
24. Wing J, Babor T, Brugha T, Burke J, Cooper J, Giel R, Jableski A, Regier D, Sartorius N: SCAN schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry 1990;47:589-593.
25. WHO: Composite International Diagnostic Interview. Geneva, WHO, 1990.
26. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296.
27. Hamilton M: Diagnosis and rating of anxiety. B J Psychiatry 1969;3:76-79.
28. Ballenger JC: Clinical guidelines for establishing remission in patients with depression and anxiety. J Clin Psychiatry 1999;60(suppl 22):29-34.
29. Leibowitz M: Social phobia. Mod Probl Pharmacopsychiatry 1987;22:141-173.
30. Marks IM, Mathews AM: Brief standard self-rating for phobic patients. Behav Res Ther 1979;17:263-267.
31. Heimberg RG, Horner KJ, Juster HR, Safren SA, Brown EJ, Schneier FR, Liebowitz MR: Psychometric properties of the Liebowitz Social Anxiety Scale. Psychol Med 1999;29:199-212.
32. Mennin DS, Fresco DM, Heimberg RG, Schneier FR, Davies SO, Liebowitz MR: Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale. J Anxiety Disord 2002;16:661-673.
33. Liebowitz MR, Mangano RM, Bradwejn J, Asnis G: A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder. J Clin Psychiatry 2005;66:238-247.
34. Cottraux J, Bouvard M, Messy P: Validation and factor analysis of a phobia scale: the French version of the Marks-Mathews fear questionnaire. Encephale 1987;13:23-29.
35. Van Zuuren FJ: The fear questionnaire: some data on validity, reliability and layout. Br J Psychiatry 1988;153:659-662.
36. Cooper J: The Leyton obsessional inventory. Psychol Med 1970;1:48-64.
37. Pilowski I: Dimensions of hypochondriasis. Br J Psychiatry 1967;113:89-93.
38. Sifneos P: The prevalence of alexithymic characteristics in psychosomatic patients. Psychother Psychosom 1973;22:255-262.
39. Compton WM 3rd, Cottler LB, Phelps DL, Ben Abdallah A, Spitznagel EL: Psychiatric disorders among drug-dependent subjects: are they primary or secondary? Am J Addict 2000;9:126-134.
40. Bakken K, Landheim AS, Vaglum P: Substance-dependent patients with and without social anxiety disorder: occurrence and clinical differences - A study of a consecutive sample of alcohol-dependent and poly-substance-dependent patients treated in two counties in Norway. Drug Alcohol Depend 2005;80:321-328.
41. Grant BF, Hasin DS, Dawson DA: The relationship between DSM-IV alcohol use disorders and DSM-IV major depression: examination of the primary-secondary distinction in a general population sample. J Affect Disord 1996;38:113-128.
42. Kushner MG, Abrams K, Thuras P, Hanson KL, Brekke M, Sletten S: Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients. Alcohol Clin Exp Res 2005;29:1432-1443.
43. Compton W, Cottler L, Jacobs J, Ben-Abdallah A, Spitznagel E: The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am J Psychiatry 2003;160: 890-895.
44. Haver B, Gjestad R: Phobic anxiety and depression as predictor variables for treatment outcome: a LISREL analysis on treated female alcoholics. Nord J Psychiatry 2005;59:25-30.
45. Pirkola S, Poikolainen K, Lönqvist J: Currently active and remitted alcohol dependence in a nationwide adult general population - results from the Finnish Health 2000 study. Alcohol Alcohol 2006;41:315-320.
46. Marquenie LA, Schade A, Van Balkom AJ, Koeter M, Frenken S, van den Brink W, van Dyck R: Comorbid phobic disorders do not influence outcome of alcohol dependence treatment: results of a naturalistic follow-up study. Alcohol Alcohol 2006;41:168-173.
47. Terra MB, Barros HM, Stein AT, Figueira I, Athayde LD, Spanemberg L, de Aguiar Possa M, Filho LD, da Silveira DX: Does co-occurring social phobia interfere with alcoholism treatment adherence and relapse? J Subst Abuse Treat 2006;31:403-409.
48. Moak DH, Anton RF, Latham PK, Voronin KE, Waid RL, Durazo-Arvizu R: Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial. J Clin Psychopharmacol 2003;23:553-562.
49. Bowen RC, D'Arcy C, Keegan D, Senthilselvan A: A controlled trial of cognitive behavioral treatment of panic in alcoholic inpatients with comorbid panic disorder. Addict Behav 2000;25:593-597.
50. Krystal JH, Staley J, Mason G, Petrakis IL, Kaufman J, Harris RA, Gelernter J, Lappalainen J: Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment. Arch Gen Psychiatry 2006;63:957-968.
51. Dodd PR, Beckmann AM, Davidson MS, Wilce PA: Glutamate-mediated transmission, alcohol, and alcoholism. Neurochem Int 2000;37:509-533.
52. Heinz A, Mann K, Weinberger DR, Goldman D: Serotonergic dysfunction, negative mood states, and response to alcohol. Alcohol Clin Exp Res 2001;25:487-495.
53. LeMarquand D, Pihl RO, Benkelfat C: Serotonin and alcohol intake, abuse, and dependence: findings of animal studies. Biol Psychiatry 1994;36:395-421.
54. LeMarquand D, Pihl RO, Benkelfat C: Serotonin and alcohol intake, abuse, and dependence: clinical evidence. Biol Psychiatry 1994;36:326-337.
55. Kienast T, Heinz A: Dopamine and the diseased brain. CNS Neurol Disord Drug Targets 2006;5:109-131.
56. Oslin DW, Berrettini WH, O'Brien CP: Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone. Addict Biol 2006;11:397-403.
57. Sanacora G, Mason GF, Krystal JH: Impairment of GABAergic transmission in depression: new insights from neuroimaging studies. Crit Rev Neurobiol 2000;14:23-45.
58. Krystal JH, D'Souza DC, Sanacora G, Goddard AW, Charney DS: Current perspectives on the pathophysiology of schizophrenia, depression, and anxiety disorders. Med Clin North Am 2001;85:559-577.
59. Gorman JM, Hirschfeld RM, Ninan PT: New developments in the neurobiological basis of anxiety disorders. Psychopharmacol Bull 2002;36(suppl 2):49-67.
60. Nemeroff CB, Vale WW: The neurobiology of depression: inroads to treatment and new drug discovery. J Clin Psychiatry 2005;66(suppl 7):5-13.
61. Fadda F, Rossetti ZL: Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog Neurobiol 1998;56: 385-431.
62. Brawman-Mintzer O, Lydiard RB, Emmanuel N, Payeur R, Johnson M, Roberts J, Jarrell MP, Ballenger JC: Psychiatric comorbidity in patients with generalized anxiety disorder. Am J Psychiatry 1993;150:1216-1218.
63. Judd LL, Kessler RC, Paulus MP, Zeller PV, Wittchen HU, Kunovac JL: Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS). Acta Psychiatr Scand Suppl 1998;393:6-11.
64. Garyfallos G, Adamopoulou A, Karastergiou A, Voikli M, Milis V, Donias S, Giouzepas J, Parashos A: Psychiatric comorbidity in Greek patients with generalized anxiety disorder. Psychopathology 1999;32:308-318.
65. Kessler RC, Keller MB, Wittchen HU: The epidemiology of generalized anxiety disorder. Psychiatr Clin North Am 2001;24:19-39.
66. Hunt C, Slade T, Andrews G: Generalized anxiety disorder and major depressive disorder comorbidity in the National Survey of Mental Health and Well-Being. Depress Anxiety 2004;20:23-31.
67. Mineka S, Watson D, Clark LA: Comorbidity of anxiety and unipolar mood disorders. Annu Rev Psychol 1998;49:377-412.
68. Hettema JM, Neale MC, Kendler KS: A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001;158:1568-1578.
69. Keller J, Nitschke JB, Bhargava T, Deldin PJ, Gergen JA, Miller GA, Heller W: Neuropsychological differentiation of depression and anxiety. J Abnorm Psychol 2000;109:3-10.
70. Boyer P: Do anxiety and depression have a common pathophysiological mechanism? Acta Psychiatr Scand Suppl 2000:24-29.
71. Choi W, Patten C, Gillin J, Kaplan R, Pierce J: Cigarette smoking predicts development of depressive symptoms among US adolescents. Ann Behav Med 1997;19:42-50.
72. Martini S, Wagner F, Anthony J: The association of tobacco smoking and depression in adolescence: evidence from the United States. Subst Use Misuse 2002;37:1853-1867.
73. Murphy J, Horton N, Monson R, Laird N, Sobol A, Leighton A: Cigarette smoking in relation to depression: historical trends from the Stirling County Study. Am J Psychiatry 2003;160:1663-1669.
74. Wang Y, Browne D, Storr C, Wagner F: Gender and the tobacco-depression relationship: a sample of African American college students at a Historically Black College or University (HBCU). Addict Behav 2005;30:1437-1441.
75. Daeppen J, Smith T, Danko G, Gordon L, Landi N, Nurnberger JJ, Bucholz K, Raimo E, Schuckit M; Collaborative Study Group on the Genetics of Alcoholism: Clinical correlates of cigarette smoking and nicotine dependence in alcohol-dependent men and women. Alcohol Alcohol 2000;35:171-175.
76. Koenig HG, Cohen HJ, Blazer DG, Krishnan KR, Sibert TE: Profile of depressive symptoms in younger and older medical inpatients with major depression. J Am Geriatr Soc 1993;41:1169-1176.
77. Baldwin DS, Evans DL, Hirschfeld RM, Kasper S: Can we distinguish anxiety from depression? Psychopharmacol Bull 2002;36(suppl 2):158-165.
78. Nutt D, Stein D: Understanding the neurobiology of comorbidity in anxiety disorders. CNS Spectr 2006;10(suppl 12):13-20.
79. Earnheart JC, Schweizer C, Crestani F, Iwasato T, Itohara S, Mohler H, Luscher B: GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states. J Neurosci 2007;27:3845-3854.
80. Hauger RL, Risbrough V, Brauns O, Dautzenberg FM: Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets 2006;5:453-479.